Sanofi-Aventis' Interest In Genzyme May Include Diagnostics Arm

Drug maker Sanofi-Aventis is signaling potential interest in Genzyme's molecular diagnostics business, suggesting that the unit could be retained if Sanofi succeeds in its quest to acquire Genzyme